Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System

ObjectivesTo develop nomograms to assess prognostic factors for 5-year overall survival (OS) and 5-year progression-free survival (PFS) in locally advanced cervical squamous cell carcinoma (LACSC).MethodsOverall, 618 patients with LACSC were included in this retrospective analysis. Nomograms for 5-y...

Full description

Bibliographic Details
Main Authors: Xi Yang, Jusheng An, Yuanyuan Zhang, Yong Yang, Siye Chen, Manni Huang, Lingying Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.591700/full
_version_ 1828900921976815616
author Xi Yang
Jusheng An
Yuanyuan Zhang
Yong Yang
Siye Chen
Manni Huang
Lingying Wu
author_facet Xi Yang
Jusheng An
Yuanyuan Zhang
Yong Yang
Siye Chen
Manni Huang
Lingying Wu
author_sort Xi Yang
collection DOAJ
description ObjectivesTo develop nomograms to assess prognostic factors for 5-year overall survival (OS) and 5-year progression-free survival (PFS) in locally advanced cervical squamous cell carcinoma (LACSC).MethodsOverall, 618 patients with LACSC were included in this retrospective analysis. Nomograms for 5-year OS and PFS were developed based on Cox proportional hazards regression models. Concordance index (C-index) and calibration curves were used to define the predictive and discriminatory capacity of the nomogram. A comparison between the nomogram and the International Federation of Gynecology and Obstetrics (FIGO) staging system was conducted using time-dependent receiver operating characteristic (tROC) and area under the curve (tAUC).ResultsMultivariate analysis identified several prognostic factors for OS including squamous cell carcinoma antigen (SCC-Ag), body mass index (BMI), tumor size, pelvic wall involvement, and para-aortic lymph node metastasis (PALNM). Prognostic factors for PFS included BMI, hemoglobin (HGB), tumor size, pelvic wall involvement, pelvic lymph node metastasis (PLNM) and PALNM. Following bootstrap correction, the C-index of OS and PFS was 0.713 and 0.686, respectively. These nomograms showed superior performance compared with the FIGO 2009 and 2018 staging schema.ConclusionsNomograms were developed to identify prognostic factors for 5-year OS and PFS in patients with LACSC. These nomograms showed good prognostication and are more comprehensive in predicting survival outcomes than existing staging criteria.
first_indexed 2024-12-13T15:53:23Z
format Article
id doaj.art-969146305d604ac3b1216272c4a66d51
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T15:53:23Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-969146305d604ac3b1216272c4a66d512022-12-21T23:39:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.591700591700Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging SystemXi Yang0Jusheng An1Yuanyuan Zhang2Yong Yang3Siye Chen4Manni Huang5Lingying Wu6Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaObjectivesTo develop nomograms to assess prognostic factors for 5-year overall survival (OS) and 5-year progression-free survival (PFS) in locally advanced cervical squamous cell carcinoma (LACSC).MethodsOverall, 618 patients with LACSC were included in this retrospective analysis. Nomograms for 5-year OS and PFS were developed based on Cox proportional hazards regression models. Concordance index (C-index) and calibration curves were used to define the predictive and discriminatory capacity of the nomogram. A comparison between the nomogram and the International Federation of Gynecology and Obstetrics (FIGO) staging system was conducted using time-dependent receiver operating characteristic (tROC) and area under the curve (tAUC).ResultsMultivariate analysis identified several prognostic factors for OS including squamous cell carcinoma antigen (SCC-Ag), body mass index (BMI), tumor size, pelvic wall involvement, and para-aortic lymph node metastasis (PALNM). Prognostic factors for PFS included BMI, hemoglobin (HGB), tumor size, pelvic wall involvement, pelvic lymph node metastasis (PLNM) and PALNM. Following bootstrap correction, the C-index of OS and PFS was 0.713 and 0.686, respectively. These nomograms showed superior performance compared with the FIGO 2009 and 2018 staging schema.ConclusionsNomograms were developed to identify prognostic factors for 5-year OS and PFS in patients with LACSC. These nomograms showed good prognostication and are more comprehensive in predicting survival outcomes than existing staging criteria.https://www.frontiersin.org/articles/10.3389/fonc.2020.591700/fullcervical squamous cell carcinomalocally advanced stageFIGO 2018 stagenomogramprognostic model
spellingShingle Xi Yang
Jusheng An
Yuanyuan Zhang
Yong Yang
Siye Chen
Manni Huang
Lingying Wu
Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
Frontiers in Oncology
cervical squamous cell carcinoma
locally advanced stage
FIGO 2018 stage
nomogram
prognostic model
title Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
title_full Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
title_fullStr Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
title_full_unstemmed Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
title_short Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
title_sort prognostic nomograms predicting survival in patients with locally advanced cervical squamous cell carcinoma the first nomogram compared with revised figo 2018 staging system
topic cervical squamous cell carcinoma
locally advanced stage
FIGO 2018 stage
nomogram
prognostic model
url https://www.frontiersin.org/articles/10.3389/fonc.2020.591700/full
work_keys_str_mv AT xiyang prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT jushengan prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT yuanyuanzhang prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT yongyang prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT siyechen prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT mannihuang prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem
AT lingyingwu prognosticnomogramspredictingsurvivalinpatientswithlocallyadvancedcervicalsquamouscellcarcinomathefirstnomogramcomparedwithrevisedfigo2018stagingsystem